Genetic News

A widely prescribed pain reliever may one day have value in helping to prevent lung cancer. Read the rest of this entry »

The long-awaited results of a trial of the biologic drug Erbitux on patients with advanced non-small cell lung cancer show it prolonged survival by about five weeks when combined with chemotherapy. Read the rest of this entry »

A panel of 15 genes may help determine which patients with early-stage non-small cell lung cancer will experience a recurrence and, therefore, benefit the most from chemotherapy, a new study shows. Read the rest of this entry »

A common genetic variant increases the risk of lung cancer, even in nonsmokers, researchers report. Read the rest of this entry »